[go: up one dir, main page]

MA37601A1 - Formulations pharmaceutiques topiques non aqueuses et non desquamantes pour utilsation comme antiacterien - Google Patents

Formulations pharmaceutiques topiques non aqueuses et non desquamantes pour utilsation comme antiacterien

Info

Publication number
MA37601A1
MA37601A1 MA37601A MA37601A MA37601A1 MA 37601 A1 MA37601 A1 MA 37601A1 MA 37601 A MA37601 A MA 37601A MA 37601 A MA37601 A MA 37601A MA 37601 A1 MA37601 A1 MA 37601A1
Authority
MA
Morocco
Prior art keywords
desquamating
nonaqueous
bacterial
pharmaceutical formulations
topical pharmaceutical
Prior art date
Application number
MA37601A
Other languages
Arabic (ar)
English (en)
Inventor
Samy Saad
Original Assignee
Samy Saad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46467014&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA37601(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Samy Saad filed Critical Samy Saad
Publication of MA37601A1 publication Critical patent/MA37601A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des formulations pharmaceutiques topiques non aqueuses qui sont non desquamantes. La formulation comprend un solvant organique ayant des propriétés de perméation de tissu, un co-solvant organique et un agent filmogène. La formulation peut en outre comprendre un agent pharmaceutique antimicrobien.
MA37601A 2012-05-02 2013-04-30 Formulations pharmaceutiques topiques non aqueuses et non desquamantes pour utilsation comme antiacterien MA37601A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2775393A CA2775393C (fr) 2012-05-02 2012-05-02 Formulations pharmaceutiques topiques non aqueuses
PCT/CA2013/000426 WO2013163734A1 (fr) 2012-05-02 2013-04-30 Formulations pharmaceutiques non aqueuses topiques

Publications (1)

Publication Number Publication Date
MA37601A1 true MA37601A1 (fr) 2016-08-31

Family

ID=46467014

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37601A MA37601A1 (fr) 2012-05-02 2013-04-30 Formulations pharmaceutiques topiques non aqueuses et non desquamantes pour utilsation comme antiacterien

Country Status (23)

Country Link
US (2) US20130296387A1 (fr)
EP (1) EP2844299A4 (fr)
JP (1) JP6382798B2 (fr)
KR (1) KR20150034685A (fr)
CN (1) CN104582734A (fr)
AP (1) AP2014008035A0 (fr)
AU (1) AU2013255026A1 (fr)
BR (1) BR112014027039A2 (fr)
CA (1) CA2775393C (fr)
CL (1) CL2014002969A1 (fr)
CO (1) CO7240372A2 (fr)
CR (1) CR20140541A (fr)
DO (1) DOP2014000247A (fr)
EA (1) EA201492011A1 (fr)
HK (1) HK1207294A1 (fr)
IL (1) IL235409A0 (fr)
IN (1) IN2014DN10033A (fr)
MA (1) MA37601A1 (fr)
PE (1) PE20150668A1 (fr)
PH (1) PH12014502441A1 (fr)
SG (1) SG11201406932VA (fr)
TN (1) TN2014000457A1 (fr)
WO (1) WO2013163734A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP1556009B2 (fr) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Mousse cosmetique et pharmaceutique
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP3124016B1 (fr) 2015-07-31 2019-09-04 Warszawski Uniwersytet Medyczny Composition d'émulsion anti-psoriasique comprenant de la céfazoline
DE102015118780A1 (de) * 2015-09-15 2017-03-16 Andre Piontek Medizinisches Pflaster
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
WO2021209025A1 (fr) * 2020-04-17 2021-10-21 Shenzhen Pharmacin Co., Ltd Compositions pharmaceutiques
CN111763706B (zh) * 2020-07-14 2023-08-18 武汉科技大学 一种应用天然免疫激活剂抗病毒的方法
EP4304594A4 (fr) * 2021-03-09 2025-03-05 Germanas, Juris Composés d'hydroxyquinoléine et leurs méthodes d'utilisation en tant qu'agents de modification de pigment

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200914B (en) * 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5702694A (en) * 1993-08-17 1997-12-30 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP3803393B2 (ja) * 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
US5547989A (en) * 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
KR20000064607A (ko) * 1996-03-16 2000-11-06 훽스트 악티엔게젤샤프트 손발톱건선치료용국소제제
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
WO1999039680A1 (fr) * 1998-02-09 1999-08-12 Macrochem Corporation Vernis a ongles antifongique et son procede d'utilisation
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US7838447B2 (en) * 2001-12-20 2010-11-23 Kimberly-Clark Worldwide, Inc. Antimicrobial pre-moistened wipers
AU2003270273B2 (en) * 2002-09-05 2009-03-19 Galderma S.A. Solution for ungual application
AU2004224326B2 (en) * 2003-03-21 2010-04-22 Nexmed Holdings, Inc. Antifungal nail coat and method of use
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20090298805A1 (en) * 2008-06-03 2009-12-03 Polson George A Topical pyrithione compositions and methods for treatment of nail fungus
BRPI1014529A2 (pt) * 2009-03-20 2015-08-25 Stiefel Laboratories Composições de monoglicerídeo de ácido graxo

Also Published As

Publication number Publication date
CL2014002969A1 (es) 2015-06-26
DOP2014000247A (es) 2015-06-30
JP6382798B2 (ja) 2018-08-29
CR20140541A (es) 2015-04-07
SG11201406932VA (en) 2014-11-27
EP2844299A4 (fr) 2016-04-20
CO7240372A2 (es) 2015-04-17
CN104582734A (zh) 2015-04-29
IL235409A0 (en) 2014-12-31
AP2014008035A0 (en) 2014-10-31
PE20150668A1 (es) 2015-05-20
US20130296387A1 (en) 2013-11-07
EA201492011A1 (ru) 2015-04-30
IN2014DN10033A (fr) 2015-08-14
EP2844299A1 (fr) 2015-03-11
KR20150034685A (ko) 2015-04-03
TN2014000457A1 (en) 2016-03-30
BR112014027039A2 (pt) 2017-06-27
US20180271836A1 (en) 2018-09-27
WO2013163734A1 (fr) 2013-11-07
PH12014502441A1 (en) 2015-01-12
CA2775393A1 (fr) 2012-07-06
HK1207294A1 (en) 2016-01-29
CA2775393C (fr) 2014-04-29
AU2013255026A1 (en) 2014-12-18
JP2015515960A (ja) 2015-06-04

Similar Documents

Publication Publication Date Title
MA37601A1 (fr) Formulations pharmaceutiques topiques non aqueuses et non desquamantes pour utilsation comme antiacterien
EA201400838A1 (ru) ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
GEP201606580B (en) Topical compositions comprising fipronil and permethrin and methods of use
BR112015001697A2 (pt) formulações de clomazona
EP2827866A4 (fr) Compositions pharmaceutiques comprenant de l'alcool benzylique
EA201500628A1 (ru) Индолкарбоксамидные производные в качестве антагонистов p2xрецепторов
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора
EA201500931A1 (ru) Производные пиридин-4-ила
EA201600434A1 (ru) Применение производных бензимидазолпролина
MX372721B (es) Ánalogos halogenados de agentes antifi-broticos.
CO7131368A2 (es) (r)-nifuratel, su uso para el tratamiento de infecciones y síntesis de (r) y (s)-nifuratel
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
EA201492280A1 (ru) Стабильный состав пексиганана
FR2966698B1 (fr) Composition dermo-cosmetique anti-microbienne pour animaux
WO2014210436A3 (fr) Agonistes opioïdes kappa et leurs utilisations
IN2014KN02584A (fr)
TR201203085A2 (tr) Sefetamet ve klavulanik asit içeren bileşimler.
TR201203087A2 (tr) Seftibüten ve klavulanik asit formülasyonları.